Funder: Harrington Discovery Institute
Due Dates: December 31, 2026 (Quarterly review) | March 31, 2027 (Quarterly review) | June 30, 2027 (Quarterly review) | September 30, 2027 (Quarterly review)
Funding Amounts: $100,000 for one year with appropriate justification; potential second-year renewal and up to $400,000 in additional funding
Summary: Research funding and drug development support for discoveries aimed at treating, preventing or curing Alzheimer's disease and related dementias.
Key Information: Applicants must hold an MD, PhD or equivalent and a faculty position at an eligible institution.
Description
The Brain Health Medicines Scholar Award is run by Harrington Discovery Institute at University Hospitals in Cleveland, Ohio. It supports researchers developing discoveries aimed at treating, preventing or curing Alzheimer's disease and related dementias. The selection committee welcomes any therapeutic modality and seeks novel, validated targets backed by rigorous science, creativity, innovation and potential for clinical impact.
The award combines research funding with hands-on development expertise to help advance discoveries toward medicines. Scholars receive a dedicated Project Manager for the award's duration and access to Harrington's Therapeutics Development Center experts in drug development, commercial strategy and business development. Projects may qualify for renewal based on achieved milestones, as well as additional funding and drug development support.
